Ultragenyx fell by 26.05 percent week-on-week as investor sentiment was largely dragged down by the Food and Drug Administration’s (FDA) rejection of its biologics license application...
Keep Reading →
July 13 - News
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising stocks according to Wall Street analysts.
Keep Reading →
July 9 - News
On July 3, Scott Wren, Wells Fargo senior global market strategist, and Adam Crisafulli, Vital Knowledge founder, joined 'Closing Bell Overtime' on CNBC to talk about the current...
Keep Reading →
July 8 - Hedge Funds, News
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2025 Earnings Call Transcript May 6, 2025Ultragenyx Pharmaceutical Inc. misses on earnings expectations.
Keep Reading →
May 8 - News, Transcripts
Wall Street is overflowing with data. If companies are not releasing their earnings, economic data flows almost daily.
Keep Reading →
April 11 - Hedge Funds, News
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
Keep Reading →
March 30 - Hedge Funds, News
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Keep Reading →
March 26 - Hedge Funds, Industries, News
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2024 Earnings Call Transcript February 13, 2025Ultragenyx Pharmaceutical Inc. misses on earnings expectations.
Keep Reading →
February 17 - News, Transcripts
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Keep Reading →
January 17 - Hedge Funds, News
Operator: Good afternoon and welcome to the Ultragenyx Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
November 7 - News, Transcripts
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
November 1 - Hedge Fund Investor Letters, News
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Keep Reading →
September 2 - Hedge Funds, Industries, News
Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
August 4 - News, Transcripts
Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-2.02505 EPS, expectations were $-1.72.
Keep Reading →
May 4 - News, Transcripts
Rivian Automotive, Inc. (NASDAQ:RIVN) manufactures and develops category-defining electric vehicles (EVs) and related accessories.
Keep Reading →
March 20 - News
In this article, we will take a look at the 10 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
Ultragenyx Pharmaceutical Inc. beats earnings expectations. Reported EPS is $-1.52, expectations were $-1.65. Ultragenyx Pharmaceutical Inc.
Keep Reading →
February 16 - News, Transcripts
In this piece, we will take a look at the 15 best strong buy stocks to invest in.
Keep Reading →
February 13 - Hedge Funds, News
In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds.
Keep Reading →
December 27 - Hedge Funds, News
In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.
Keep Reading →
December 15 - Hedge Funds, News
Operator: Good afternoon, and welcome to the Ultragenyx Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
November 4 - News, Transcripts
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Keep Reading →
November 4 - Hedge Funds, News
In this article, we discuss 5 biotech stocks with biggest upside.
Keep Reading →
September 9 - News
In this article, we will take a look at the 10 healthcare stocks to buy.
Keep Reading →
August 12 - Hedge Funds, Lists
In this article, we discuss 15 worst performing biotech stocks in 2023.
Keep Reading →
August 8 - Hedge Funds, News, Stock Analysis
Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Keep Reading →
August 4 - News, Transcripts
In this article, we will take a look at the 5 oversold biotech stocks to buy.
Keep Reading →
July 29 - News
In this piece, we will take a look at the ten best economic recovery stocks to buy.
Keep Reading →
July 12 - Hedge Funds, News
In this piece, we will take a look at the five best revenue growth stocks to buy.
Keep Reading →
July 11 - News
Investing these days is a ride not for the faint hearted.
Keep Reading →
June 9 - Hedge Funds, News
Operator: Good afternoon, and welcome to the Ultragenyx First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Keep Reading →
May 5 - News, Transcripts
In this article, we discuss 5 most promising biotech stocks according to analysts.
Keep Reading →
February 25 - News
Operator: Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2022 Financial Results Conference Call.
Keep Reading →
February 20 - News, Transcripts
In this article, we will be looking at 12 stocks to sell according to Motley Fool.
Keep Reading →
February 19 - Hedge Funds, News
In this article, we discuss 5 stocks you should sell according to Motley Fool.
Keep Reading →
April 28 - Hedge Funds, News
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Keep Reading →
December 11 - Hedge Funds, News
In this article, we discuss the top 10 pharmaceutical stocks to buy based on billionaire Ken Griffin’s portfolio.
Keep Reading →
December 10 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
October 18 - Hedge Funds, News
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Keep Reading →
July 13 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
April 20 - Hedge Funds, News
In this article we talk about 15 fastest growing biotech companies in the US.
Keep Reading →
February 27 - Lists, News
Crispin Odey’s flagship hedge fund lost money again in 2020, deepening the gloom for the bearish manager as he tries to revive his shrinking firm and fights an indecent assault...
Keep Reading →
January 6 - Hedge Funds, Insider Trading
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Keep Reading →
December 17 - Hedge Funds, News
Bill Miller's Fund Crushed the Market for a Record 15 Straight Years.
Keep Reading →
November 3 - Hedge Funds, Insider Trading
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
September 29 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
August 10 - Hedge Funds, News
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Keep Reading →
June 23 - Hedge Funds, News
A judge has dismissed a lawsuit brought by a hedge fund against the widow of one of the fund’s employees.
Keep Reading →
May 21 - Hedge Funds, Insider Trading
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 29 - Hedge Funds, News
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Keep Reading →
December 10 - Hedge Funds, News
